By designating just one reference outlined drug because the standard to which all generic variations should be demonstrated to get bioequivalent, FDA hopes to avoid achievable sizeable versions among the generic drugs and their model name counterpart. Affected individual help packages (PAPs) are usually sponsored by pharmaceutical companies and